(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IONIS PHARMACEUTICALS

This trademark appears in the official USPTO history.

Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.

CANCELLED SEC. 8 (6-YR)Type: CombinedOffice: United States

Quick snapshot

IONIS PHARMACEUTICALS

ST13

US500000086845666

Class

5

Filing

86845666

Registration

5978398

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

CANCELLED SEC. 8 (6-YR)

Case type

Application and registration

Recorded events

58

Latest update

08/14/2026

Trademark type

Combined

Nice classes

5

Filing date

12/10/2015

Registration date

02/04/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/14/2026

Last transaction

08/14/2026

Responsible office

United States Patent and Trademark Office

Status code

710

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/03/2019

First use in commerce

12/03/2019

Drawing code

3

Owner type

03

Owner location

Carlsbad, CA, US

Examiner

PARKS, KIMBERLY L

Law office

M30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the words "IONIS PHARMACEUTICALS" to the right of a pyramid design element.

Holders and representatives

Holders

IONIS PHARMACEUTICALS, INC.
IONIS PHARMACEUTICALS, INC.
Isis Pharmaceuticals, Inc.

Representatives

Brian Focarino Cooley LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

diagnostic preparations and human therapeutics for medical useantisense oligonucleotides

Publications

History of USPTO decisions and trademark events.

58 publications found

C8..

CANCELLED SEC. 8 (6-YR)

08/14/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/03/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/03/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/03/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/03/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/03/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/04/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

09/25/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/25/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/25/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/25/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/25/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/25/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/04/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/31/2019

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/30/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/27/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/26/2019

EX5G

SOU EXTENSION 5 GRANTED

12/26/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/26/2019

IUAF

USE AMENDMENT FILED

12/17/2019

EXT5

SOU EXTENSION 5 FILED

12/17/2019

EEXT

SOU TEAS EXTENSION RECEIVED

12/17/2019

EISU

TEAS STATEMENT OF USE RECEIVED

12/17/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/15/2019

EX4G

SOU EXTENSION 4 GRANTED

06/13/2019

EXT4

SOU EXTENSION 4 FILED

06/13/2019

EEXT

SOU TEAS EXTENSION RECEIVED

06/13/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/21/2018

EX3G

SOU EXTENSION 3 GRANTED

12/19/2018

EXT3

SOU EXTENSION 3 FILED

12/19/2018

EEXT

SOU TEAS EXTENSION RECEIVED

12/19/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/15/2018

EX2G

SOU EXTENSION 2 GRANTED

06/13/2018

EXT2

SOU EXTENSION 2 FILED

06/13/2018

EEXT

SOU TEAS EXTENSION RECEIVED

06/13/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/16/2017

EX1G

SOU EXTENSION 1 GRANTED

12/14/2017

EXT1

SOU EXTENSION 1 FILED

12/14/2017

EEXT

SOU TEAS EXTENSION RECEIVED

12/14/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/20/2017

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

05/04/2017

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

11/23/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/25/2016

PUBO

PUBLISHED FOR OPPOSITION

10/25/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/05/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/17/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/16/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/15/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/15/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/24/2016

GNRT

NON-FINAL ACTION E-MAILED

03/24/2016

CNRT

NON-FINAL ACTION WRITTEN

03/24/2016

DOCK

ASSIGNED TO EXAMINER

03/22/2016

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/03/2016

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/16/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/15/2015

NWAP

NEW APPLICATION ENTERED

12/14/2015

Continuous trademark protection

Get notified about every new filing that threatens IONIS PHARMACEUTICALS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.